ANI Pharmaceuticals Inc (ANIP)
61.45
-2.32
(-3.64%)
USD |
NASDAQ |
May 17, 16:00
61.45
0.00 (0.00%)
After-Hours: 16:52
ANI Pharmaceuticals Gross Profit (Quarterly): 88.27M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 88.27M |
December 31, 2023 | 78.23M |
September 30, 2023 | 83.73M |
June 30, 2023 | 74.26M |
March 31, 2023 | 69.08M |
December 31, 2022 | 57.91M |
September 30, 2022 | 50.93M |
June 30, 2022 | 38.56M |
March 31, 2022 | 30.21M |
December 31, 2021 | 27.03M |
September 30, 2021 | 27.65M |
June 30, 2021 | 26.31M |
March 31, 2021 | 34.54M |
December 31, 2020 | 32.71M |
September 30, 2020 | 32.86M |
June 30, 2020 | 27.78M |
March 31, 2020 | 27.97M |
December 31, 2019 | 30.17M |
September 30, 2019 | 36.34M |
June 30, 2019 | 38.72M |
March 31, 2019 | 38.16M |
December 31, 2018 | 36.99M |
September 30, 2018 | 35.10M |
June 30, 2018 | 30.68M |
March 31, 2018 | 25.79M |
Date | Value |
---|---|
December 31, 2017 | 26.84M |
September 30, 2017 | 27.09M |
June 30, 2017 | 23.64M |
March 31, 2017 | 20.24M |
December 31, 2016 | 21.30M |
September 30, 2016 | 21.86M |
June 30, 2016 | 19.54M |
March 31, 2016 | 17.14M |
December 31, 2015 | 14.50M |
September 30, 2015 | 16.71M |
June 30, 2015 | 16.38M |
March 31, 2015 | 16.05M |
December 31, 2014 | 17.36M |
September 30, 2014 | 14.33M |
June 30, 2014 | 4.53M |
March 31, 2014 | 8.277M |
December 31, 2013 | 7.848M |
September 30, 2013 | 5.126M |
June 30, 2013 | 3.981M |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | 0.1104M |
June 30, 2012 | 0.1088M |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
26.31M
Minimum
Jun 2021
88.27M
Maximum
Mar 2024
45.66M
Average
35.44M
Median
Gross Profit (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 28.10M |
ADMA Biologics Inc | 39.11M |
Annovis Bio Inc | -- |
United Therapeutics Corp | 604.80M |
Moderna Inc | 71.00M |